Eva C.
- Country
- Spain
- Department
- Oncology
Research Overview
- Evaluation of Tumor Infiltrating Lymphocytes in Advanced or Metastatic Triple-Negative Breast Cancer Patients
- Phase 1/1b Evaluation of IAM1363 in Patients with Relapsed/Refractory HER2-Altered Malignancies
- A Phase I First-in-Human Dose Escalation Study to Evaluate the Safety and Efficacy of ARI-HER2 (HER2BBz CAR-T Cells) in Patients with HER2-Positive Advanced Breast Cancer
Data & Insights
Has run more than one trial at 333 of 661 partner sites.
Specializations
Early Stage Breast Cancer Research
Specializes in investigating therapeutic approaches for node-positive, estrogen receptor-positive, HER2-negative early breast cancer with high recurrence risk. Conducts long-term follow-up studies examining outcomes in invasive breast cancer patients.
- Early-stage disease progression
- Endocrine therapy optimization
- Recurrence risk assessment
Focuses on evaluating treatment efficacy in terms of invasive breast cancer-free survival.
Advanced Breast Cancer Treatment
Investigates novel therapeutic approaches for metastatic breast cancer, with particular emphasis on hormone receptor-positive and HER2-positive disease variants. Studies innovative drug combinations and targeted therapies.
- HER2-positive metastatic disease
- Hormone receptor-positive advanced cancer
- Novel therapeutic combinations
Evaluates treatment responses in advanced disease settings, including specific patient populations.
Brain Metastasis Research
Leads investigations into treatments for brain metastases from ER-positive, HER2-negative breast cancer. Studies combination therapies and their efficacy in managing central nervous system involvement.
- Brain metastasis management
- Combination therapy assessment
- Treatment response monitoring
Focuses on developing effective therapeutic strategies for patients with brain metastases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.